MariMed to Launch Top-Selling Betty’s Eddies Brand Into Maine Adult-Use Cannabis Marketplace
Ryan Allway June 30th, 2022 News, Top News NORWOOD, Mass., June 29, 2022 (GLOBE NEWSWIRE) — MariMed, Inc. (“MariMed” or the “Company”) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced a licensing agreement with East Coast Cannabis Company, a vertical cannabis producer... Read more
Allied Corp Successfully Ships First Commercial Cannabis Flower Export From Colombia to International Market
Ryan Allway June 29th, 2022 News, Top News KELOWNA, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) — Allied Corp. (“Allied” or the “Company”) (OTCQB: ALID) is pleased to announce that it has completed the first shipment of commercial dried cannabis from Colombia to an international market. On April 01, 2022 Colombia... Read more
Texas Original Opens Drive-Thru Medical Cannabis Pickup Location in Waco, Texas
Ryan Allway June 28th, 2022 News, Top News AUSTIN, Texas, June 28, 2022–(BUSINESS WIRE)–Texas Original, Texas’ leading medical cannabis provider, announced its newest prescription pickup location has opened in Waco, Texas. The new location is Waco’s first medical cannabis pickup site and the first drive-thru location in the state.... Read more
Heritage Cannabis Reports Q2 2022 Financial Results
Ryan Allway June 28th, 2022 News, Top News TORONTO, June 28, 2022–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company“), today announced its financial results as at and for the three- and six-month periods ended April 30, 2022 (“Q2 2022“). All figures are in Canadian dollars unless... Read more
Akanda’s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK
LONDON–(BUSINESS WIRE)-June 28, 2022-Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis platform company, today announced that its UK import and distribution wholly-owned subsidiary CanMart Ltd. (“CanMart”) has partnered with Phlo Connect and Cellen Life Sciences (“Cellen”) to create a first-of-its-kind fully digital dispensing collaboration for... Read more
Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of Major Depressive Disorder
Ryan Allway June 27th, 2022 Psychedelics, Top News — Marks the first novel psilocybin analog to enter clinical development —— Patient recruitment to commence immediately —— Pharmacokinetic and safety data readout expected in Q4 2022 — TORONTO, June 27, 2022–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company... Read more
Artelo Biosciences Presents Positive Pre-Clinical Results of ART26.12, a Novel FABP5 Inhibitor, in Alleviating Chemotherapy-Induced Pain
Ryan Allway June 27th, 2022 News, Top News Presentation delivered by Professor Saoirse O’Sullivan at the 32nd Annual ICRS Symposium in Galway, Ireland on Sunday, June 26th SOLANA BEACH, Calif., June 27, 2022 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for... Read more
PharmAla Biotech Registers Trademark for MDMA
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Leafly Set to Join Russell 3000® and Russell 2000® Index
Ryan Allway June 24th, 2022 News, Top News SEATTLE–(BUSINESS WIRE)– Leafly Holdings, Inc. (“Leafly” or “the Company”) (NASDAQ: LFLY), is set to join the broad-market Russell 3000 Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the US market opens on June 27, 2022, according to... Read more
Tryp Therapeutics Appoints New Chief Operating Officer
Sid Taubenfeld with Extensive Experience in the Financial Markets and as a Biotech Executive Joins Tryp as Company Prepares to Expand Patient Access to Psilocybin-Based Treatments San Diego, California — (June 23, 2022) – Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the “Company”), a clinical-stage biotechnology company focused... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )